Clinical trial · Observational
Observational Study of the Decision Making Towards Clinical Trials in Cancer Patients
The Study of the Knowledge, Attitudes, and Decision Making Towards Clinical Trials in Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a cross-sectional, observational and correlational survey study.This study is aim to survey the the knowledge, attitudes, and decision making towards clinical trials in cancer patients in Taiwan (R.O.C.), which attempts to invite some cancer patients who have been experienced the treatment clinical trials' informed consent process. The research tool is a questionnaire which includes some scale: (1)Clinical trial Knowledge scale, (2) Attitude toward randomized clinical trials scale, (3) Shared Decision Making(SDM-Q-9),(4) Satisfaction with Decision (SWD-scale), and (5) Decision Regret scale(DRS). The investigators expect the research outcome can provide some instructions to improve patients' autonomy, satisfaction of the decision making and communication process between patients and Medical professors whenever cancer patients participating in clinical trials.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Cancer | Malignant Liver Neoplasm | CURATED_EXACT | 0.92 |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- The influencing factors of behavior intentions towards participating in clinical trials
- timeFrame
- in 24 months
- description
- The influencing factors was defined as following measurement scale: 1. Knowledge 2. Attitude 3. decision making process 4. sex 5. age 6. education
Secondary outcomes (4)
- measure
- The knowledge towards clinical trials in cancer patients
- timeFrame
- 24 months
- measure
- The attitudes towards clinical trials in cancer patients
- timeFrame
- in 24 months
- measure
- The shared decision making level towards clinical trials in cancer patients
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: 1. Cancer patients who have been approved lung cancer or liver cancer. 2. Patients who have been experienced the Informed consent process about clinical trial, which duration is in 6 months before they enter this study. Exclusion Criteria: 1. Patients who have conscious disorientation that can not answer questionnaire 2. Patients only participate in some Gene clinical trials without treatment or drugs.
References
Publications (0)
Data not yet available